New treatments for asthma using specialized beta-2 receptor drugs
Novel Biased Beta2-AR Ligands as Asthma Therapeutics
['FUNDING_R01'] · DUKE UNIVERSITY · NIH-11021053
This study is exploring new types of asthma medications that could help you breathe better without the usual side effects, aiming to make asthma treatment safer and more effective for everyone.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DUKE UNIVERSITY (nih funded) |
| Locations | 1 site (DURHAM, UNITED STATES) |
| Trial ID | NIH-11021053 on ClinicalTrials.gov |
What this research studies
This research investigates innovative beta-2 adrenergic receptor (b2AR) ligands that aim to improve asthma treatment. The approach focuses on developing new agonists and allosteric modulators that can provide therapeutic benefits without the common side effects associated with traditional b-agonists. By utilizing advanced genetic and molecular techniques, the research seeks to understand the mechanisms behind asthma exacerbation and improve the safety and efficacy of asthma medications. Patients may benefit from these new treatments that could lead to better asthma control and fewer complications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with asthma who are currently using beta-agonist medications.
Not a fit: Patients with asthma who do not respond to beta-agonists or have contraindications to their use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective asthma therapies that improve patient outcomes.
How similar studies have performed: Previous research has shown promise in developing safer alternatives to traditional asthma treatments, indicating potential for success in this novel approach.
Where this research is happening
DURHAM, UNITED STATES
- DUKE UNIVERSITY — DURHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WALKER, JULIA K L — DUKE UNIVERSITY
- Study coordinator: WALKER, JULIA K L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.